S. CROS - Concepedia

Author

S. CROS

Centre National de la Recherche Scientifique

Also Known As

Cros, S., S CROS, S Cros, S. B. Cros, S. CROS, S. Cros, Sandrine Cros

Publications

678

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Laboratoire de Recherche en Sciences Végétales Institut de Chimie des Substances Naturelles Inserm

About

S. CROS is an author at Centre National de la Recherche Scientifique specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	330
2	Biochemistry	6	6	166
3	Natural Sciences	5	5	148
4	Engineering	1	1	46
5	Public Health	1	1	46

S. CROS

Publications

620

Citations

H-Index

Page 1

	Year	Citations
Experimental antitumor activity of Navelbine. S. CROS, Matthew C. Wright, M. Morimoto, PubMed Molecular PharmacologyMedicinal ChemistryExperimental Antitumor ActivityMedicinePharmacotherapy	1989	128
Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Bernard Monsarrat, E Mariel, S. CROS, Drug Metabolism and Disposition	1990	117
LIMITS OF TOXIC AND TERATOGENIC TOLERANCE OF DIMETHYL SULFOXIDE F Caujolle, D Caujolle, S. CROS, Annals of the New York Academy of Sciences Environmental ChemistryChemical SafetyToxicologyEcotoxicologyEnvironmental Toxicology	1967	72
Hydrophobicity parameters for platinum complexes Jean Pierre Souchard, Tam T. B. Ha, S. CROS, Journal of Medicinal Chemistry EngineeringAltmetric Attention ScoreBibliometricsOrganic ChemistryChemistry	1991	46
Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363. Laurence Kraus‐Berthier, G Atassi, S. CROS, PubMed Pharmaceutical SciencePathologyPharmacotherapyPharmaceutical ChemistryTumor Biology	1991	44
Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection. Le Pecq Jb, Charlie Gosse, Nguyen‐Dat‐Xuong, PubMed Antitumor ActivityImmunologyPharmacotherapyTumor BiologyDrug Resistance	1976	36
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl. Christian Auclair, Emmanuelle Voisin, O. Pepin, PubMed Pharmaceutical SciencePharmacotherapyChemical BiologyEnzymatic ModificationPharmaceutical Chemistry	1987	35
The antitumor activity of some palladium(II) complexes with chelating ligands. Wimmer Fl, Smita Wimmer, Paule Castan, PubMed Antitumor ActivityChemoprevention StrategyChemistryPharmaceutical ChemistryInorganic Compound	1989	34
The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies? Gérard Meunier, Dominique de Montauzon, Jean Bernadou, Molecular Pharmacology	1988	33
Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs Claude Paoletti, P. Lecointe, P. Lesca, Biochimie Medicinal ChemistryPharmaceutical ScienceDerivativesBioorganic ChemistryBiochemistry	1978	23

Page 1